slimvictor
Bluelight Crew
Terrine Friday, National Post · Friday, Aug. 20, 2010
Researchers are waiting anxiously for final consent from Health Canada to import the illegal drug Ecstasy for a study on the treatment of post-traumatic stress disorder.
Vancouver-based Dr. Ingrid Pacey and Andrew Feldmar will use methylenedioxymethamphetamine (MDMA), also known as Ecstasy, in their double-blind study once they get a licence authorizing the import of the pharmaceutical-grade drug from Switzerland.
...
The purpose of using psychedelic drugs such as MDMA to treat post-traumatic stress is that "these drugs wake you up" while pharmaceutical drugs often "put you to sleep," said Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies.
In a study published in the Journal of Psychopharmacology last month, research funded by Mr. Doblin's association found that 10 of 12 patients treated with MDMA no longer suffered from the disorder after treatment. With these results, the U.S. Food and Drug Administration approved the testing of MDMA on U.S. war veterans last month.
Read more: http://www.nationalpost.com/news/ca...asy+approval/3420323/story.html#ixzz0xOxpaDQW
Researchers are waiting anxiously for final consent from Health Canada to import the illegal drug Ecstasy for a study on the treatment of post-traumatic stress disorder.
Vancouver-based Dr. Ingrid Pacey and Andrew Feldmar will use methylenedioxymethamphetamine (MDMA), also known as Ecstasy, in their double-blind study once they get a licence authorizing the import of the pharmaceutical-grade drug from Switzerland.
...
The purpose of using psychedelic drugs such as MDMA to treat post-traumatic stress is that "these drugs wake you up" while pharmaceutical drugs often "put you to sleep," said Rick Doblin, founder and executive director of the Multidisciplinary Association for Psychedelic Studies.
In a study published in the Journal of Psychopharmacology last month, research funded by Mr. Doblin's association found that 10 of 12 patients treated with MDMA no longer suffered from the disorder after treatment. With these results, the U.S. Food and Drug Administration approved the testing of MDMA on U.S. war veterans last month.
Read more: http://www.nationalpost.com/news/ca...asy+approval/3420323/story.html#ixzz0xOxpaDQW
